The public health basis of cancer screening: principles and ethical aspects

  • Anthony B. Miller
Part of the Cancer Treatment and Research book series (CTAR, volume 86)

Abstract

Cancer is a dread disease. It ably fulfills, at least in the mind of the public and of many physicians, two of the requirements for screening, namely, that the disease should be an important public health problem and that the consequences of untreatable cancer are dire [1]. However, we do not have a screening test for cancer; rather, we have a series of screening tests for different cancer sites. These tests use different approaches, possess varying sensitivity and specificity, and have produced varying evidence of efficacy and effectiveness. Thus screening for each cancer site has to be justified on its own merits and must therefore be evaluated using rigorous approaches, especially randomized controlled trials [2].

Keywords

Europe Tate Neuroblastoma Parkin Mandel 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Miller AB. 1982. Fundamental issues in screening. In Schottenfeld D, Fraumeni JF Jr (eds.), Cancer Epidemiology and Prevention. Philadelphia: W.B. Saunders, pp. 1064–1074.Google Scholar
  2. 2.
    Prorok PC, Chamberlain J, Day NE, Hakama M, Miller AB. 1984. UICC Workshop on the evaluation of screening programmes for cancer. Int J Cancer 34: 1–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Cole P, Morrison AS. 1980. Basic issues in population screening for cancer. J Natl Cancer Inst 64: 1263–1272.PubMedGoogle Scholar
  4. 4.
    Miller AB. 1994. Screening for cancer: Is it time for a paradigm shift? Ann R Coll Physicians Surgeons Canada 27: 353–355.Google Scholar
  5. 5.
    Miller AB. 1985. Principles of screening and of the evaluation of screening programs. In Miller AB (ed.), Screening for cancer. Orlando, FL: Academic Press, pp. 3–24.Google Scholar
  6. 6.
    Ponten J, Adami HO, Bergstrom R, Dillner J, Friberg LG, Gustafsson L, Miller AB, Parkin DM, Sparen P, Trichopoulos D. 1995. Strategies for global control of cervical cancer. Int J Cancer 60: 1–26.PubMedCrossRefGoogle Scholar
  7. 7.
    Miller AB, Baines CJ, To T, Wall C, et al. 1992. Canadian national breast screening study: 1. Breast cancer detection and death rates among women age 40–49 years. Can Med Assoc J 147: 1459–1476.Google Scholar
  8. 8.
    Miller AB, Baines CJ, To T, Wall C, et al. 1992. Canadian national breast screening study: 2. Breast cancer detection and death rates among women age 50–59 years. Can Med Assoc J 147: 1477–1488.Google Scholar
  9. 9.
    Hakama M, Chamberlain J, Day NE, Miller AB, Prorok PC. 1985. Evaluation of screening programmes for gynaecological cancer. Br J Cancer 52: 669–673.PubMedCrossRefGoogle Scholar
  10. 10.
    Miller AB. 1995. Editorial: Failures of cervical cancer screening. Am J Public Health 85: 761–762.PubMedCrossRefGoogle Scholar
  11. 11.
    Auvinen A, Rietbergen JBW, Denis LJ, Prorok PC, Schröder FH, for the International Prostate Cancer Screening Trial Evaluation Group. In preparation. Prospective evaluation plan for randomized trials of prosate cancer screening.Google Scholar
  12. 12.
    Beahrs OH, Shapiro S, Smart S. 1979. Report of the working group to review the National Cancer Institute-American Cancer Society Breast Cancer Detection Demonstration Projects. J Natl Cancer Inst 62: 641–709.Google Scholar
  13. 13.
    Mandel JS, Bond J, Snover D, Williams S, Bradley M, Walker C, Schuman LM, Gilbertsen V. 1988. The University of Minnesota’s Colon Cancer Control Study. In Chamberlain J, Miller AB (eds.), Screening for Gastrointestinal Cancer. Toronto: Hans Huber, pp. 17–24.Google Scholar
  14. 14.
    Chamberlain J. 1986. Reasons that some screening programmes fail to control cervical cancer. In Hakama M, Miller AB, Day NE (eds.), Screening for Cancer of the Cervix Uteri. IARC Scientific Publications No. 76. Lyon: International Agency for Research on Cancer, pp. 161–168.Google Scholar
  15. 15.
    Chamberlain J, Day NE, Hakama M, Miller A, Prorok PC. 1986. UICC workshop of the project on evaluation of screening programmes for gastrointestinal cancer. Int J Cancer 37: 329–334.PubMedCrossRefGoogle Scholar
  16. 16.
    Day NE, Baines CJ, Chamberlain J, Hakama M, Miller AB, Prorok P. 1986. UICC project on screening for cancer: report of the workshop on screening for breast cancer. Int J Cancer 38: 303–308.PubMedCrossRefGoogle Scholar
  17. 17.
    Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC. 1990. Report on a workshop of the UICC Project on evaluation of screening for cancer. Int J Cancer 46: 761–769.PubMedCrossRefGoogle Scholar
  18. 18.
    Miller AB. 1993. Canadian National Breast Screening Study: Public health implications. Can J Public Health 84: 14–16.PubMedGoogle Scholar
  19. 19.
    Greenwald P, Sondik EJ (eds.). 1986. Cancer control objectives for the nation: 1985–2000. NCI Monographs, No. 2.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Anthony B. Miller

There are no affiliations available

Personalised recommendations